Relapsed Refractory Acute Myeloid Leukemia Aml clinical trials

Explore recruiting relapsed refractory acute myeloid leukemia aml clinical trials.

Recruiting relapsed refractory acute myeloid leukemia aml studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed Refractory Acute Myeloid Leukemia Aml trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

MAATEO: A phase 1 study in patients with hematological malignancies to evaluate safety, tolerability and efficacy of Karonudib

Sweden, Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

An adaptive open-label multicentre phase 1/2 trial, to determine the recommended phase 2 dose of CCTx-001, and to assess safety, tolerability, and clinical activity in patients with relapsed/refractory acute myeloid leukaemia (RESOLVE AML 001)

Germany, Spain, Sweden, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Relapsed Refractory Acute Myeloid Leukemia Aml trials by city

Relapsed Refractory Acute Myeloid Leukemia Aml in Toronto Relapsed Refractory Acute Myeloid Leukemia Aml in Vancouver Relapsed Refractory Acute Myeloid Leukemia Aml in Montreal Relapsed Refractory Acute Myeloid Leukemia Aml in Calgary Relapsed Refractory Acute Myeloid Leukemia Aml in Edmonton Relapsed Refractory Acute Myeloid Leukemia Aml in Ottawa Relapsed Refractory Acute Myeloid Leukemia Aml in Winnipeg Relapsed Refractory Acute Myeloid Leukemia Aml in Quebec City Relapsed Refractory Acute Myeloid Leukemia Aml in Hamilton Relapsed Refractory Acute Myeloid Leukemia Aml in Kitchener Relapsed Refractory Acute Myeloid Leukemia Aml in London Relapsed Refractory Acute Myeloid Leukemia Aml in Halifax Relapsed Refractory Acute Myeloid Leukemia Aml in New York Relapsed Refractory Acute Myeloid Leukemia Aml in Los Angeles Relapsed Refractory Acute Myeloid Leukemia Aml in Chicago Relapsed Refractory Acute Myeloid Leukemia Aml in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease